EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles

Sinei Ramos Soares, Maria Karoliny da Silva Torres, Sandra Souza Lima, Kevin Matheus Lima de Sarges iD, Erika Ferreira Dos Santos iD, Mioni Thieli Figueiredo Magalhães de Brito iD, Andréa Luciana Soares da Silva iD, Mauro de Meira Leite iD, Flávia Póvoa da Costa iD, Marcos Henrique Damasceno Cantanhede, Rosilene da Silva iD, Adriana de Oliveira Lameira Veríssimo und 9 weitere

Viruses · 2023

DOI: 10.3390/v15040898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Sinei Ramos Soares und 20 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação Amazônia de Amparo a Estudos e Pesquisa do Pará, Secretaria de Ciência, Tecnologia e Educação Superior, Profissional e Tecnológica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The first case of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in Brazil was diagnosed on February 26, 2020. Due to the important epidemiological impact of COVID-19, the present study aimed to analyze the specificity of IgG antibody responses to the S1, S2 and N proteins of SARS-CoV-2 in different COVID-19 clinical profiles. This study enrolled 136 individuals who were diagnosed with or without COVID-19 based on clinical findings and laboratory results and classified as asymptomatic or as having mild, moderate or severe disease. Data collection was performed through a semistructured questionnaire to obtain demographic information and main clinical manifestations. IgG antibody responses to the S1 and S2 subunits of the spike (S) protein and the nucleocapsid (N) protein were evaluated using an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s instructions. The results showed that among the participants, 87.5% (119/136) exhibited IgG responses to the S1 subunit and 88.25% (120/136) to N. Conversely, only 14.44% of the subjects (21/136) displayed S2 subunit responses. When analyzing the IgG antibody response while considering the different proteins of the virus, patients with severe disease had significantly higher antibody responses to N and S1 than asymptomatic individuals (p ≤ 0.0001), whereas most of the participants had low antibody titers against the S2 subunit. In addition, individuals with long COVID-19 showed a greater IgG response profile than those with symptomatology of a short duration. Based on the results of this study, it is concluded that levels of IgG antibodies may be related to the clinical evolution of COVID-19, with high levels of IgG antibodies against S1 and N in severe cases and in individuals with long COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansAntibodies, ViralAntibody FormationImmunoglobulin GNucleocapsid ProteinsPost-Acute COVID-19 SyndromeSARS-CoV-2Spike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

COVID-19IgG antibodiesSARS-CoV-2immunity

Substanzen

Antibodies, ViralImmunoglobulin GNucleocapsid ProteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
  • Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Universidade Federal do Pará, Belém 66075-110, Brazil.
  • Laboratório de Genética de Doenças Complexas, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
  • Hospital Adventista de Belém, Belém 66093-904, Brazil.
  • Centro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Belém 66050-540, Brazil.
  • Laboratório de Pesquisas Básicas em Malária em Malária, Seção de Parasitologia, Instituto Evandro Chagas, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Ministério da Saúde do Brasil, Ananindeua 70068-900, Br…

ORCID-Profile: Kevin Matheus Lima de Sarges, Erika Ferreira Dos Santos, Mioni Thieli Figueiredo Magalhães de Brito, Andréa Luciana Soares da Silva, Mauro de Meira Leite, Flávia Póvoa da Costa, Rosilene da Silva, Rosimar Neris Martins Feitosa, Luiz Fábio Magno Falcão, Eduardo José Melo Dos Santos, Antonio Carlos Rosário Vallinoto

Förderung

  • National Council for Scientific and Technological Development
  • Fundação Amazônia de Amparo a Estudos e Pesquisa do Pará
  • Secretaria de Ciência, Tecnologia e Educação Superior, Profissional e Tecnológica

Zitieren

APA

Soares, S. R., da Silva Torres, M. K., Lima, S. S., de Sarges, K. M. L., Santos, E. F. D., de Brito, M. T. F. M., da Silva, A. L. S., de Meira Leite, M., da Costa, F. P., Cantanhede, M. H. D., da Silva, R., de Oliveira Lameira Veríssimo, A., Vallinoto, I. M. V. C., Feitosa, R. N. M., Quaresma, J. A. S., Chaves, T. D. S. S., Viana, G. M. R., Falcão, L. F. M., Santos, E. J. M. D., …, & da Silva, A. N. M. R. (2023). Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles. Viruses. https://doi.org/10.3390/v15040898

Vancouver

Soares SR, da Silva Torres MK, Lima SS, de Sarges KML, Santos EFD, de Brito MTFM, et al. Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles. Viruses. 2023. doi:10.3390/v15040898

BibTeX
@article{Soares2023,
  author = {Soares, Sinei Ramos and da Silva Torres, Maria Karoliny and Lima, Sandra Souza and de Sarges, Kevin Matheus Lima and Santos, Erika Ferreira Dos and de Brito, Mioni Thieli Figueiredo Magalhães and da Silva, Andréa Luciana Soares and de Meira Leite, Mauro and da Costa, Flávia Póvoa and Cantanhede, Marcos Henrique Damasceno and da Silva, Rosilene and de Oliveira Lameira Veríssimo, Adriana and Vallinoto, Izaura Maria Vieira Cayres and Feitosa, Rosimar Neris Martins and Quaresma, Juarez Antônio Simões and Chaves, Tânia do Socorro Souza and Viana, Giselle Maria Rachid and Falcão, Luiz Fábio Magno and Santos, Eduardo José Melo Dos and Vallinoto, Antonio Carlos Rosário and da Silva, Andréa Nazaré Monteiro Rangel},
  title = {Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15040898}
}
Kostenlos starten →